Home > Inc 5000 AI Prospecting Database > Gilead Sciences

AI Prospecting for Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's primary areas of focus include HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

Company data:

Company size:

18000 employees

Website URL:

https://www.gilead.com

Industry

Biotechnology

Headquarters:

Foster City, California, USA

Investment round:

Publicly Traded (NASDAQ: GILD)

ARR:

$27 billion

Key stakeholders

These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates

Andrew D. Dickinson

Chief Financial Officer

Christopher John

Regional President

Michelle Bribiesca

President

Latest news about Gilead Sciences

Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates

Gilead Sciences will release its first quarter 2025 financial results on April 24, 2025, after market close, followed by a webcast at 4:30 p.m. ET. The company also presented new HIV treatment and cure research data at CROI 2025, including an investigational long-acting, twice-yearly therapy option[2][3][4].

Gilead Sciences announced a 2.6% increase in its quarterly cash dividend for the first quarter of 2025, resulting in a $0.79 per share dividend payable on March 28, 2025, to stockholders of record as of March 14, 2025[4].

Gilead Sciences announced no other significant recent news beyond the financial results and dividend increase. However, it is noteworthy that the company has been actively involved in presenting new HIV treatment and cure research data, though this was not specified as the most recent news item to be highlighted[2][3][4].

Open job positions at Gilead Sciences

This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

Associate Director, Opinion Leader Programming, HCV/HBV

Senior Product Manager, HIV Prevention, DTC Marketing

Associate Director, Patient Access Solutions FRM Access & Reimbursement, Market Access Lead

AI sales outreach emails you can send to Gilead Sciences

See samples of how AiSDR handles your outbound emails with the prospecting data available

See how AiSDR will sell to you.

Share your info and get the first-hand experience

Start scaling your sales outreach today!